Biohaven Pharmaceutical Holding Co Ltd.

Swiss National Bank

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/9/2022

Shares

143,200

Value ($000)

21,648

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/9/2022	21,648	0.0%	143,200	9/30/2022
2022 Q2	8/9/2022	20,589	0.0%	141,300	6/30/2022
2022 Q1	5/9/2022	16,529	0.0%	139,400	3/31/2022
2021 Q4	2/8/2022	17,860	0.0%	129,600	12/31/2021
2021 Q3	11/8/2021	17,975	0.0%	129,400	9/30/2021
2021 Q2	8/6/2021	11,543	0.0%	118,900	6/30/2021
2021 Q1	5/7/2021	7,963	0.0%	116,500	3/31/2021
2020 Q4	2/5/2021	9,831	0.0%	114,700	12/31/2020
2020 Q3	11/9/2020	7,333	0.0%	112,800	9/30/2020
2020 Q2	8/5/2020	8,086	0.0%	110,600	6/30/2020
2020 Q1	5/8/2020	2,927	0.0%	86,000	3/31/2020
2019 Q4	2/6/2020	4,617	0.0%	84,800	12/31/2019